Ambulatorio Dottoressa Elena Battaglia

10/12/2024

Per tutti i Pazienti Cannabici ricordatevi di mandare la richiesta per la ricetta per tempo che durante le feste le Farmacie non spediscono .

29/11/2024

SI RENDE NOTO CHE DAL 31/12/2024 CESSERA’ IL MIO RAPPORTO DI CONSULENZA CON LA DITTA RIMOS . RIMANGO , COME SEMPRE A DISPOSIZIONE DEI COLLEGHI CHE ABBIANO DUBBI O DOMANDE SU EVENTUALI TERAPIE CON I CANNABINOIDI ALLA MAIL : [email protected]

29/11/2024

Abbiamo un nuovo prodotto !!!
SEC DERMA !!

Crema per uso esterno per animali da affezione

29/11/2024

EFFICACIA DEL SEC CONTRO LA CONCORRENZA .

23/11/2024

https://www.cannabisterapeutica.info/it/cannabis-animali-oncologici-racconto-veterinaria.html

Dal Sistema Endocannabinoide alla terapie con la cannabis per gli animali oncologici, il nuovo articolo della veterinaria Elena Battaglia che analizza i benefici

22/11/2024

Parrebbe che il decreto sicurezza verrà discusso verso metà dicembre . Il decreto include la fine della coltivazione della canapa in Italia. A parte dire quanto era id**ta questo provvedimento , vi ricordo di fare scorta di Cbd . Poi vedremo se e quando verrà fatto ricorso.

04/11/2024

PER I PAZIENTI CANNABICI:

1- I referti vanno mandato SEMPRE E SOLO alla mail
2- chiedere le ricette quando si è a metà del secondo flacone altrimenti non si può assicurare che arrivi in tempo la cannabis
3 - la diluizione della cannabis è su 50 ml , non si può avere un numero dispari di flaconi.

19/10/2024

has been trending in the cannabis world. But why?

Kelly Preston (our Extern and the owner of Farley's Green Paw Consulting) explains.

"While the exact mechanisms through which CBG may combat cancer in pets are still being investigated, several potential pathways are being explored:

Modulating the endocannabinoid system: The endocannabinoid system (ECS) is a complex network of receptors and signaling molecules found throughout the body. CBG may interact with these receptors, potentially influencing cancer cell growth and behavior. The ECS plays a crucial role in regulating various physiological processes, including pain, mood, and immune response. By interacting with the ECS, CBG may be able to influence the behavior of cancer cells, potentially inhibiting their growth and spread.

Reducing inflammation: By reducing inflammation, CBG may create a more favorable environment for the immune system to fight cancer cells and alleviate pain associated with the disease. Chronic inflammation is often linked to cancer development and progression, and reducing it can help create a more conducive environment for the immune system to function effectively.

Protecting healthy cells: CBG's antioxidant and neuroprotective properties can help safeguard healthy cells from damage caused by cancer or its treatment. This is particularly important, as cancer treatments can often have negative side effects on healthy cells. By protecting healthy cells, CBG may help reduce the overall impact of cancer and its treatment on the pet's well-being.

Potentiating the effects of other treatments: CBG may work synergistically with other cancer treatments, such as chemotherapy or radiation therapy, enhancing their effectiveness while potentially reducing side effects. This could be particularly beneficial for pets undergoing traditional cancer treatments, as it may help improve the efficacy of these treatments while minimizing their negative side effects."

Read her full blog post (and check out the product she mentions by Earth Buddy Pet) via Farley's Green Paw Consulting website.

https://www.farleysgreenpawconsulting.com/post/cbg-pet-cancer-treatment?fbclid=IwY2xjawFqBpxleHRuA2FlbQIxMQABHab5ttj7V-GxblbngW-X7bY7atuXpi-pFaALrzDQI78IHetpM38LhezJ_g_aem_2qrk9kFeXAZbHfOBoN3heA

14/10/2024

VCS Board Member Dr. Elena Battaglia brought this interesting study to our attention. It offers an in-depth overview of the science of the endocannabinoid system in animals.

Title: Endocannabinoid system and phytocannabinoids in the main species
of veterinary interest: a comparative review

Authors: Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna, Giorgia della Rocca

Abstract: "Since the discovery of the endocannabinoid system and due to the empirical evidence of the therapeutic effects on several illnesses both in humans and animals that follow the administration of exogenous cannabinoids (i.e., phytocannabinoids), numerous studies have been conducted. These investigations aimed to identify the expression and distribution of cannabinoid receptors in healthy and pathologic organs and tissues of different animal species and to define the interactions of phytocannabinoids with these receptors. In the last decade, pharmacokinetics, efficacy and tolerability of many Cannabis derivatives formulations, mainly containing cannabidiol, in the main species of veterinary interest, have been also investigated. This manuscript summarizes the findings reported by the scientific studies published so far on the molecular
mode of action of the main phytocannabinoids, the localization of cannabinoid receptors in organs and tissues, as well as the pharmacokinetics, efficacy and tolerability of Cannabis derivatives in dogs, cats, horses and other species of veterinary interest. A deep knowledge of these issues is crucial for the use of phytocannabinoids for therapeutic purposes in animal species."

Find the full study in our Curated Research Library and in the journal of Veterinary Research Communications.

14/10/2024

Diretta della scorsa settimana su Epilessia e Cannabinoidi

In questo incontro de I Salotti di EpyPet, in collaborazione con Nutravet - un gruppo ad approccio clinico e sistemico alla nutrizione del cane e del gatto -...

10/10/2024

https://www.facebook.com/share/HUTmvhVKTdQeJCPx/?mibextid=WC7FNe

Our Board Member, Dr. Elena Battaglia, is proud to call the authors of this study her colleagues and friends! Even as the Italian government continues to threaten restrictions on cannabis and CBD, Dr. Elena and her colleagues remain dedicated to its study and application. They're veterinary heroes!

Title: Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge

Date: June 2023

Authors: Alessandra Di Salvo, Maria Beatrice Conti, Giorgia della Rocca

Summary: "Despite a certain number of available pharmacokinetic studies, the kinetic profile of CBD has yet to be fully known, probably because of the very different experimental conditions. In terms of efficacy, most studies have tested CBD’ ability to relieve osteoarthritic pain. In contrast, few studies have evaluated its role in epilepsy, behavioral disorders, and skin lesions. From obtained results, some evidence exists supporting the beneficial role of CBD. Nevertheless, the limited number of published studies and the occurrence of bias in almost all require caution in interpreting findings. From tolerability studies, CBD’ side effects can be classified as mild or unremarkable. However, studies were prevalently focused on short- to medium-term treatment, while CBD is usually employed for long-term treatment. Further studies are warranted to define better whether CBD could be a valid adjunct in canine treatment."

Find the full study in our Curated Research Library and Frontiers in Veterinary Medicine!

02/10/2024

Cannabis per animali: i consigli della veterinaria Elena Battaglia e del farmacista Matteo Mantovani per un trattamento corretto a base di cannabis

26/09/2024

https://www.facebook.com/share/v/XQBMFn6abEV9ipA9/?mibextid=WC7FNe

16/09/2024

Torna questo martedì alle 21.30 l’appuntamento con Ambulatorio Dottoressa Elena Battaglia per parlare degli usi della cannabis in medicina veterinaria…!!!

Vi aspettiamo 🙏🏻🐾

16/09/2024

Per chi ha chiesto per la società americana dei link precedenti. Questo è cosa si ottiene aderendo come “ pet parent”.

Our Mission is to create lasting solutions that ensure the safe use of cannabis in pets through education, advocacy, and promoting product standards.